New patent for Avadel Cns drug LUMRYZ
Annual Drug Patent Expirations for LUMRYZ Lumryz is a drug marketed by Avadel Cns and is included in one NDA. […]
Patent Added
New patent for Taiho Oncology drug LYTGOBI
Annual Drug Patent Expirations for LYTGOBI Lytgobi is a drug marketed by Taiho Oncology and is included in one NDA.
New patent for Boehringer Ingelheim drug SYNJARDY XR
Annual Drug Patent Expirations for SYNJARDY+XR Synjardy Xr is a drug marketed by Boehringer Ingelheim and is included in one
New patent for Boehringer Ingelheim drug SYNJARDY XR Read Post »
New patent for Heron Theraps drug ZYNRELEF KIT
Annual Drug Patent Expirations for ZYNRELEF+KIT Zynrelef Kit is a drug marketed by Heron Theraps Inc and is included in
New patent for Boehringer Ingelheim drug TRIJARDY XR
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one
New patent for Boehringer Ingelheim drug TRIJARDY XR Read Post »
New patent for Vanda Pharms drug HETLIOZ LQ
Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in
New patent for Boehringer Ingelheim drug JARDIANCE
Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA.
New patent for Boehringer Ingelheim drug JARDIANCE Read Post »
New patent for Vanda Pharms drug HETLIOZ
Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two
New patent for Boehringer Ingelheim drug GLYXAMBI
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA.
New patent for Boehringer Ingelheim drug GLYXAMBI Read Post »
